Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PNT | Common Stock | Sale | -$4.24M | -564K | -15.73% | $7.51 | 3.02M | May 25, 2022 | Direct | F1 |
holding | PNT | Common Stock | 233K | May 25, 2022 | 1510789 Ontario Inc. | F2 | |||||
holding | PNT | Common Stock | 358 | May 25, 2022 | Trust Controlled by Wife | F3 |
Id | Content |
---|---|
F1 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.75, inclusive. The reporting person undertakes to provide to POINT Biopharma Global Inc., any security holder of POINT Biopharma Global Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
F2 | A corporation controlled by Reporting Person. |
F3 | A trust, whose trustee is the Reporting Person's spouse. |